BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6806220)

  • 1. Analysis of residual disease following preoperative radiotherapy versus initial surgery in endometrial carcinoma.
    Chung CK; Stryker JA; Nahhas WA; Cunningham DE; Mortel R
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):213-8. PubMed ID: 6806220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of residual disease after radiotherapy in endometrial carcinoma: clinicopathologic correlation.
    Macasaet M; Brigati D; Boyce J; Nicastri A; Waxman M; Nelson J; Fruchter R
    Am J Obstet Gynecol; 1980 Nov; 138(5):557-63. PubMed ID: 7425019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial adenocarcinoma: therapeutic impact of preoperative histopathologic examination of endometrial tissue.
    Oakley G; Nahhas WA
    Eur J Gynaecol Oncol; 1989; 10(4):255-60. PubMed ID: 2776782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the endometrium stage I. Treatment, survival and recurrence.
    Philipsen T; Nørgård M
    Acta Obstet Gynecol Scand; 1984; 63(1):51-5. PubMed ID: 6720256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual carcinoma in the surgical specimen of patients with endometrial adenocarcinoma undergoing preoperative radiation therapy. A study of 80 patients and a literature review.
    Nahhas WA; Zaino R; Mortel R
    Gynecol Oncol; 1984 Jun; 18(2):165-76. PubMed ID: 6735261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary clear cell carcinoma of the endometrium: a clinicopathologic study of 20 cases.
    Kanbour-Shakir A; Tobón H
    Int J Gynecol Pathol; 1991; 10(1):67-78. PubMed ID: 2007536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I endometrial adenocarcinoma: treatment results in 835 patients.
    Lotocki RJ; Copeland LJ; DePetrillo AD; Muirhead W
    Am J Obstet Gynecol; 1983 May; 146(2):141-5. PubMed ID: 6846429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in endometrial cancer.
    Rakar S; Kovacic J
    Eur J Gynaecol Oncol; 1990; 11(3):233-5. PubMed ID: 2209644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adenocarcinoma of the endometrium.
    Jones HW
    Obstet Gynecol Surv; 1975 Mar; 30(3):147-69. PubMed ID: 1091895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of histologic grade in stage II endometrial carcinoma.
    Goplerud DR; Belgrad R
    Surg Gynecol Obstet; 1979 Mar; 148(3):406-8. PubMed ID: 419444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery.
    Chen SS
    Cancer; 1989 May; 63(9):1843-5. PubMed ID: 2702593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of high-grade stage I adenocarcinoma of the endometrium: hysterectomy following low dose external beam pelvic irradiation.
    Shimm DS; Wang CC; Fuller AF; Nelson JH; Nikrui N; Young RH; Scully RE
    Gynecol Oncol; 1986 Feb; 23(2):183-91. PubMed ID: 3943760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of endometrial adenocarcinoma with cervical involvement.
    Rubin SC; Hoskins WJ; Saigo PE; Nori D; Mychalczak B; Chapman D; Lewis JL
    Gynecol Oncol; 1992 Jun; 45(3):294-8. PubMed ID: 1612507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors.
    Nori D; Hilaris BS; Tome M; Lewis JL; Birnbaum S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):489-97. PubMed ID: 3104248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma.
    Komaki R; Cox JD; Hartz AJ; Wilson JF; Mattingly R
    Cancer; 1986 Aug; 58(4):873-9. PubMed ID: 3719554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
    Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system.
    Grigsby PW; Perez CA; Kuten A; Simpson JR; Garcia DM; Camel HM; Kao MS; Galakatos AE
    Int J Radiat Oncol Biol Phys; 1992; 22(5):905-11. PubMed ID: 1555983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients.
    Aalders JG; Abeler V; Kolstad P
    Gynecol Oncol; 1984 Jan; 17(1):64-74. PubMed ID: 6693053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of tumor grade by preoperative curettage and associated clinicopathologic factors in clinical stage I endometriod adenocarcinoma.
    Wang XY; Pan ZM; Chen XD; Lü WG; Xie X
    Chin Med J (Engl); 2009 Aug; 122(16):1843-6. PubMed ID: 19781357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
    Ambros RA; Kurman RJ
    Cancer; 1992 Mar; 69(6):1424-31. PubMed ID: 1371712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.